Story · Medicine & Biotech

Finally, a Vaccine for Cancer

1 outlet · first reported by NYT Health on

Trial results for a melanoma vaccine by Merck and Moderna found that patients who received it after surgery to remove tumors were 42 percent less likely to have a recurrence or to die within two years. (NYT Health)

Coverage, in order

  1. NYT Health mainstream podcast
    Finally, a Vaccine for Cancer

    Trial results for a melanoma vaccine by Merck and Moderna found that patients who received it after surgery to remove tumors were 42 percent less likely to have a recurrence or to die within two years.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.